Skip to main content
Clinical Trials/ISRCTN10993769
ISRCTN10993769
Completed
N/A

Maxillary sinus augmentation with A-RRF and serum albumin-coated allograft- prospective randomized trial for the determination of the optimal healing time for dental implant loading

Semmelweis University Doctoral School of Clinical Medicine0 sites30 target enrollmentOctober 16, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bone allografting to support dental implants
Sponsor
Semmelweis University Doctoral School of Clinical Medicine
Enrollment
30
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2021 Results article in https://doi.org/10.3390/ma14071810 (added 15/04/2021)

Registry
who.int
Start Date
October 16, 2019
End Date
January 2, 2020
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Semmelweis University Doctoral School of Clinical Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Systemically healthy patients aged over 18 years
  • 2\. Requiring implant prostheses and oral rehabilitation
  • 3\. Insufficient residual height in posterior maxilla requiring a sinus augmentation from lateral approach to insert the implants (residual crest height \=5 mm)

Exclusion Criteria

  • 1\. Current pregnancy or intention to become pregnant during the study follow\-up period
  • 2\. Sinusitis
  • 3\. Smoking
  • 4\. Alcoholism
  • 5\. Severe haematological disorder or disease
  • 6\. History of chronic hepatitis or liver cirrhosis
  • 7\. Diabetes mellitus with poor metabolic control
  • 8\. Receiving dialysis
  • 9\. Metabolic bone disease
  • 10\. Taking bisphosphonates drugs whether orally or intravenously

Outcomes

Primary Outcomes

Not specified

Similar Trials